Table 4.
Results of blood biochemical indices in NSCLC patients at different stages of radiotherapy.
| Pre-RT (n = 16) | RT (n = 16) | Post-RT (n = 16) | |
|---|---|---|---|
| CRP | 20.78 (0.3–83.99) | 35.88 (0.5–150.865) | 25.57 (0.35–114.43) |
| WBC | 6.73 (3–12.8) | 6.49 (2.3–11) | 5.08 (2.73–8.4)# |
| Neutrophil (×109) | 7.48 (2.28–42.85) | 7.18 (1.68–38.45) | 5.5 (1.67–25.19) |
| PLT (×109) | 257 (146–394) | 220.56 (130–412) | 186.13 (79–332)## |
| Hb (g/l) | 127.44 (87–183) | 123.03 (84–153) | 119.31 (65–147) |
| Lymphocyte (×109) | 1.18 (0.5–2.59) | 1.03 (0.42–1.88) | 0.91 (0.28–2.54) |
| ALT (U/l) | 20.25 (7–50) | 48.53 (4–225) | 40.31 (4–163) |
| AST (U/l) | 32.88 (15–158) | 58.09 (13–216) | 53.5 (9–160) |
| GGT (U/l) | 77.5 (16–367) | 135.97 (13–660) | 157.25 (14–863) |
| ALP (U/l) | 124.13 (52–239) | 138.84 (38–242) | 122.69 (37–198) |
| Albumin (g/l) | 35.5 (27–48) | 34.16 (29–40) | 32.53 (22–45) |
| Globulin (g/l) | 33.63 (23–55) | 33.03 (26–43) | 34.07 (27–47) |
| Tbil (μmol/l) | 11.21 (3–25.8) | 8.26 (3–12.3) | 9.71 (5–24) |
| Direct bilirubin (μmol/l) | 1.93 (0–3.8) | 0.38 (0–2.6)∗∗ | 0.41 (0–3)### |
| Creatinine (μmol/l) | 68.56 (42–96) | 68.59 (42–99) | 68.88 (36–90) |
| UA (μmol/l) | 317.13 (192–508) | 290.84 (169–466) | 274.31 (107–551) |
| Carbamide (mmol/l) | 5.54 (3.4–9.8) | 6.25 (2.5–12) | 5.83 (2.8–10) |
Data are presented as mean (interquartile range). pre-RT: preradiotherapy; RT: radiotherapy; post-RT: postradiotherapy; WBC: white blood cell; CRP: C-reactive protein; PLT: platelet; Hb: hemoglobin; ASL: glutamic oxalacetic transaminase; ALT: glutamic-pyruvic transaminase; GGT: gamma-glutamyl transferase; ALP: alkaline phosphatase; Tbil: total bilirubin; UA: uric acid; pre-RT vs RT, ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001; pre-RT vs post-RT, #p < 0.05, ##p < 0.01, and ###p < 0.001.